Thursday May 22, 2008
Palace at Somerset Park, 333 Davidson Ave, Somerset, NJ 08873
Invited Speakers
- “Process Chemistry at GlaxoSmithKline, The Development of a Manufacturing Route to a Cathepsin K Inhibitor”
William Clark & Robert W. Marquis (GlaxoSmithKline) - “Discovery and Development of SGLT-2 Inhibitors”
Prashant Desphande & Wei Meng (Bristol Myers Squibb) - “Natural Products in Drug Discovery: The Development of Cancidas®”
James Balkovec (Merck Research Laboratories) - “From R1479 to R1626: Discovery and Advancement of 4’-Substituted Nucleosides for the Treatment of Hepatitis C”
David Smith (Roche) - “The Discovery of Varenicline, a Nicotinic Receptor Partial Agonist for Smoking Cessation”
Jotham Coe (Pfizer)
It is a great honor to serve as Chair for 2024. I look forward to leading this incredible and diverse group of volunteers . . . My goals for 2024 start with supporting our diverse topical groups and committees in organizing exciting seminars.